Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Minot Light Capital Partners Tom Wetherald and Eddie Reilly | “Xtract One Technologies is one of the leading providers of automated weapons detection systems for sports and entertainment venues, schools, hospitals, manufacturing facilities, and offices. Xtract's business model is moving towards a majority of revenues being recurring. Currently, the split between system sales being cash upfront vs subscription is about even, depending on the quarter. However, over time, the company will look to shift the majority of sales to a multi-year recurring revenue model, which has historically demonstrated very little churn. After numerous conversations with the company's CEO Peter Evans and CFO Karen Hersh over the past year and watching them execute consistently, we do think highly of Xtract One's management and how efficiently they have managed the business while growing at very high rates. The company is now essentially cashflow positive with a net cash balance sheet. Following the release of Xtract One's newest product (Xtract One Gateway), which is seeing great traction in the marketplace, we believe it is very well positioned to be a leading competitor to Evolv. Xtract One now has a revenue run-rate of about $35M and is certainly a top-three competitor in an underpenetrated market that is projected to be worth tens of billions of dollars going forward. Though the Xtract One story is only getting better in many regards, it still trades at a meaningful discount to both Evolv and our assessment of long-term fair value. This is because it is a micro-cap company that trades primarily in Canada with a small revenue base that is just turning profitable. Management's goal is to put up a few more quarters of profitability and steady growth, as well as shift the revenue mix more heavily towards recurring revenue via subscription sales. At that point, we believe the company will look to uplist onto a major US exchange. When we look out several years, we can easily envision a company trading on a major US exchange, doing at least $100M in revenues (the majority of which is recurring), with gross margins of 65% and EBITDA margins greater than 20%. If this scenario comes to fruition, we believe the company would be worth at least US$500M vs the current mkt cap of CA$143M (~US$100M).” | NEUTRAL | Q2 2026 Jul 21, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.